FOI 5326 – State And Territory Chief Health Officers' Comments On Draft Biotoxin Clinical Pathway, March-April 2023

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

State and Territory Chief Health Officers were circulated a draft Biotoxins (Indoor Damp and Mould) Clinical Pathway by the Australian Health Protection Principal Committee (AHPPC) in February-March 2023 for notation by 10 March 2023. The pathway document was finalised following this consultation process. The disclosure consists primarily of email correspondence routing the clinical pathway to Chief Health Officers from Western Australia, Queensland, New South Wales, Victoria, South Australia, Tasmania, and the Australian Capital Territory for endorsement. Western Australia's Chief Health Officer Andrew Robertson noted the pathway on behalf of the state. The specific clinical guidance content and recommendations within the Biotoxins Clinical Pathway itself are not detailed in the available excerpt, though the document was prepared by AHPPC's Emergency Management Division to provide guidance on managing health impacts associated with indoor damp and mould exposure.